title: Reply to Rees et al. Acute tubulointerstitial nephritis following treatment with exenatide.
authors.forename: H
authors.initials: H
authors.lastname: Nandakoban
authors.forename: J
authors.initials: J
authors.lastname: Flack
authors.forename: T
authors.initials: T
authors.lastname: Furlong
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D009395:Nephritis, Interstitial / Q000139:chemically induced*; D010455:Peptides / Q000009:adverse effects*; D014688:Venoms / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms